CTT Pharmaceutical Holdings, Inc.'s Form 4 filing
CTT Pharmaceutical Holdings, Inc. (CTTH) · filed Sep 23, 2025
- Accession no.
- 0001035422-25-000013
- Filed
- Sep 23, 2025, 10:52 AM ET
- Trade date
- Aug 1-2, 2025
- Filing delay
- 53 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $1.98K. It was filed 53 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| CTT Pharmaceutical Holdings, Inc.CIK 0001035422 | Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | CTTH | AGrant or awardAcquired | +750,000 | $0.04 | +$30,000 | 7,716,856 | Direct | |
| Aug 2, 2025 | CTTH | PPurchaseAcquired | +44,085 | $0.045 | +$1,983.83 | 7,760,941 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.